These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 8805320)

  • 21. Cocaine inhibits the release of MPP+ but not dopamine through the rat dopamine transporter.
    Kitayama S; Morita K; Dohi T
    Eur J Pharmacol; 1996 Aug; 309(1):107-9. PubMed ID: 8864700
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cocaine self-administration in dopamine-transporter knockout mice.
    Rocha BA; Fumagalli F; Gainetdinov RR; Jones SR; Ator R; Giros B; Miller GW; Caron MG
    Nat Neurosci; 1998 Jun; 1(2):132-7. PubMed ID: 10195128
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cocaine receptor: biochemical characterization and structure-activity relationships of cocaine analogues at the dopamine transporter.
    Carroll FI; Lewin AH; Boja JW; Kuhar MJ
    J Med Chem; 1992 Mar; 35(6):969-81. PubMed ID: 1552510
    [No Abstract]   [Full Text] [Related]  

  • 24. Dopamine-transporter occupancy after intravenous doses of cocaine and methylphenidate in mice and humans.
    Gatley SJ; Volkow ND; Gifford AN; Fowler JS; Dewey SL; Ding YS; Logan J
    Psychopharmacology (Berl); 1999 Sep; 146(1):93-100. PubMed ID: 10485970
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cloning of the cocaine-sensitive bovine dopamine transporter.
    Usdin TB; Mezey E; Chen C; Brownstein MJ; Hoffman BJ
    Proc Natl Acad Sci U S A; 1991 Dec; 88(24):11168-71. PubMed ID: 1722321
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biogenic amine flux mediated by cloned transporters stably expressed in cultured cell lines: amphetamine specificity for inhibition and efflux.
    Wall SC; Gu H; Rudnick G
    Mol Pharmacol; 1995 Mar; 47(3):544-50. PubMed ID: 7700252
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The dopamine transporter expression level differentially affects responses to cocaine and amphetamine.
    Cagniard B; Sotnikova TD; Gainetdinov RR; Zhuang X
    J Neurogenet; 2014; 28(1-2):112-21. PubMed ID: 24673634
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Locomotor sensitization and decrease in [3H]mazindol binding to the dopamine transporter in the nucleus accumbens are delayed after chronic treatments by GBR12783 or cocaine.
    Boulay D; Duterte-Boucher D; Leroux-Nicollet I; Naudon L; Costentin J
    J Pharmacol Exp Ther; 1996 Jul; 278(1):330-7. PubMed ID: 8764367
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Caenorhabditis elegans gene T23G5.5 encodes an antidepressant- and cocaine-sensitive dopamine transporter.
    Jayanthi LD; Apparsundaram S; Malone MD; Ward E; Miller DM; Eppler M; Blakely RD
    Mol Pharmacol; 1998 Oct; 54(4):601-9. PubMed ID: 9765501
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The dopamine transporter. The cloned target site of parkinsonism-inducing toxins and of drugs of abuse.
    Pifl C; Giros B; Caron MG
    Adv Neurol; 1996; 69():235-8. PubMed ID: 8615133
    [No Abstract]   [Full Text] [Related]  

  • 31. Effect of dopaminergic drugs on the in vivo binding of [3H]WIN 35,428 to central dopamine transporters.
    Scheffel U; Steinert C; Kim SE; Ehlers MD; Boja JW; Kuhar MJ
    Synapse; 1996 Jun; 23(2):61-9. PubMed ID: 8723710
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Studies of the mechanism of inhibition of the dopamine uptake carrier by cocaine in vitro using rotating disk electrode voltammetry.
    McElvain JS; Schenk JO
    Ann N Y Acad Sci; 1992 Jun; 654():480-2. PubMed ID: 1632608
    [No Abstract]   [Full Text] [Related]  

  • 33. Evidence that pure uptake inhibitors including cocaine interact slowly with the dopamine neuronal carrier.
    Héron C; Costentin J; Bonnet JJ
    Eur J Pharmacol; 1994 Nov; 264(3):391-8. PubMed ID: 7698180
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Selective dopamine transporter inhibition by cocaine analogs.
    Boja JW; McNeill RM; Lewin AH; Abraham P; Carroll FI; Kuhar MJ
    Neuroreport; 1992 Nov; 3(11):984-6. PubMed ID: 1482769
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 2'-Substitution of cocaine selectively enhances dopamine and norepinephrine transporter binding.
    Seale TW; Avor K; Singh S; Hall N; Chan HM; Basmadjian GP
    Neuroreport; 1997 Nov; 8(16):3571-5. PubMed ID: 9427328
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of dopamine transporter and locomotor effects of cocaine, GBR 12909, epidepride, and SCH 23390 in C57BL and DBA mice.
    Womer DE; Jones BC; Erwin VG
    Pharmacol Biochem Behav; 1994 Jun; 48(2):327-35. PubMed ID: 8090798
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cocaine abuse: hard knocks for the dopamine hypothesis?
    Caine SB
    Nat Neurosci; 1998 Jun; 1(2):90-2. PubMed ID: 10195118
    [No Abstract]   [Full Text] [Related]  

  • 38. Dissection of dopamine and cocaine binding sites on the rat dopamine transporter expressed in COS cells.
    Kitayama S; Morita K; Dohi T; Wang JB; Davis SC; Uhl GR
    Ann N Y Acad Sci; 1996 Oct; 801():388-93. PubMed ID: 8959052
    [No Abstract]   [Full Text] [Related]  

  • 39. A triple mutation in the second transmembrane domain of mouse dopamine transporter markedly decreases sensitivity to cocaine and methylphenidate.
    Chen R; Han DD; Gu HH
    J Neurochem; 2005 Jul; 94(2):352-9. PubMed ID: 15998286
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-lasting behavioral sensitization to psychostimulants following p-chloroamphetamine-induced neurotoxicity in mice.
    Itzhak Y; Achat-Mendes CN; Ali SF; Anderson KL
    Neuropharmacology; 2004 Jan; 46(1):74-84. PubMed ID: 14654099
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.